MODERN TREATMENT OF PARKINSONISM

被引:45
作者
BIRKMAYER, W
NEUMAYER, E
机构
来源
ZEITSCHRIFT FUR NEUROLOGIE | 1972年 / 202卷 / 04期
关键词
D O I
10.1007/BF00316175
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:257 / +
页数:1
相关论文
共 109 条
[1]  
AJURIAGUERRA J, 1971, MONOAMINES NOYAUX GR, P327
[2]  
AJURIAGUERRA JD, 1971, MONOAMINES NOYAUX GR
[3]  
AMIN AH, 1953, 19 INT PHYS C MONTR, P165
[4]  
ANDERSON M, 1951, Rass Neuropsichiatr, V5, P22
[5]  
ASHCROFT GW, 1966, LANCET, V2, P1049
[6]  
BARBEAU A, 1969, CAN MED ASSOC J, V101, P791
[7]  
Barbeau A, 1962, MONOAMINES SYSTEME N
[8]  
Barbeau A, 1970, L DOPA PARKINSONISM
[9]   DECREASE OF CEREBRAL 5-HYDROXYTRYPTAMINE BY 3,4-DIHYDROXYPHENYLALANINE AFTER INHIBITION OF EXTRACEREBRAL DECARBOXYLASE [J].
BARTHOLINI, G ;
DAPRADA, M ;
PLETSCHER, A .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1968, 20 (03) :228-+
[10]   INCREASE OF CEREBRAL CATECHOLAMINES CAUSED BY 3,4-DIHYDROXYPHENYLALANINE AFTER INHIBITION OF PERIPHERAL DECARBOXYLASE [J].
BARTHOLINI, G ;
BURKARD, WP ;
PLETSCHER, A ;
BATES, HM .
NATURE, 1967, 215 (5103) :852-+